Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This phase IV trial investigates how to personalize treatments (such as medications and/or
counseling) for quitting smoking based on the unique character traits of participants.
Nicotine replacement therapy, counseling, and/or drugs such as varenicline and bupropion may
help participants quit smoking or change smoking behavior. This trial may also help doctors
individualize smoking cessation treatment for participants who do not quit smoking after the
first course of treatment.